(Q43105940)

English

Serum and gene expression profile of tumor necrosis factor-alpha and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration

scientific article published in January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Serum and gene expression profile of tumor necrosis factor-alpha and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Carmen Mora-Fernández

1 reference

ORCID Public Data File 2021

author name string

J Navarro-Gonzalez

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

C Mora-Fernandez

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

M Gomez-Chinchon

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

M Muros

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

H Herrera

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

J Garcia

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

International Journal of Immunopathology and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

51-59

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Vascular inflammation: a role in vascular disease in hypertension?

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Inflammatory mechanisms of diabetic complications

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Atheroprotective Effects of Long-Acting Dihydropyridine-Type Calcium Channel Blockers: Evidence from Clinical Trials and Basic Scientific Research

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Amlodipine inhibits pro-inflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide/interferon-gamma-stimulated cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES)

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

TGF-beta and TNF-alpha producing effects of losartan and amlodipine on human mononuclear cell culture

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300105

21 January 2018

Identifiers

10.1177/039463201002300105

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43105940&oldid=1980872790"